WELCOME

Welcome to customer education section! Here, you can learn all about our innovative products: Squirrel Chaser app and the Squirrel Tamer neuromodulation headset. Our goal is to help you maximize the health benefits these products offer by providing instructions and insights into their features & functions as well as our research in the exciting area of science..

Please note that while our products have undergone clinical trials, they have not been reviewed by the FDA.

The Science behind squirrel chaser

How to wear Squirrel Chaser with glasses

Proper placement for therapeutic benefits

Neuroplasticity Basics

How to wear Squirrel Chaser with long hair

Easily place headset each session

Clinical Results

Several researchers including WeVibin, have discovered that adults with ADHD may experience low cerebral blood flow (CBF). This scan is from a 29 year old female with ADHD, currently taking medication. The top scan shows inadequate blood flow throughout, also suggesting that the medication did not positively effect CBF.

The 2nd scan shows the results of using Squirrel Tamer. CBF was immediately increased into the normal range. This image was taken after 5 min to see the immediate effects. With longer sessions and continued use, cerebral blood flow increases throughout the entire brain.

Here's why that's important:

Cerebral blood flow directly governs oxygen and glucose delivery, neurovascular coupling, and waste clearance. Regions with high cognitive demand are especially sensitive to perfusion deficits.

The clinical benefits of improved cerebral blood flow for Attention/Cognitive Performance include:

Enhanced executive function, particularly in working memory, inhibitory control, and task-switching; these domains can be heavily impaired in ADHD.
Improved catecholamine signaling (dopamine and norepinephrine) as blood flow correlates with metabolic demand in synaptic areas.
Reduction of default-mode interference, where mind-wandering and task disengagement are driven by improper network switching, are helped by restoring perfusion symmetry across the Default Mode Network and task-positive networks.

Studies using arterial spin labeling (ASL) MRI and PET scans show chronic hypoperfusion (low cerebral blood flow) in the temporal lobes, anterior cingulate cortex, and insular cortex in adults with ASD. The clinical benefits of improved cerebral blood flow for Autism include:

Improved connectivity in the social cognition networks, particularly in the temporoparietal junction and ventromedial prefrontal cortex.
Better sensory integration due to improved perfusion in the insula, a hub for interoception and multisensory convergence.
Possibly enhanced GABA/glutamate balance, as perfusion supports astrocytic function and neurotransmitter recycling in cortical circuits involved in social-emotional processing.

Concussions (common in sports) and other traumatic brain injuries (common in car accidents) often leads to microvascular damage, blood-brain barrier dysfunction, and long-term hypoperfusion, especially in the frontal lobes and hippocampus. Cerebral blood flow is not only reduced throughout the brain, but the brain's autoregulatory capacity can become ineffective/diminished.

The clinical benefit of increased CBF for concussions and TBI's include the following:

Supports neuroplasticity and repair, particularly in the subacute and chronic phases by facilitating:
- Neurogenesis in the dentate gyrus (hippocampus)
- Angiogenesis and axonal sprouting via VEGF and BDNF pathways
Restores cognitive function (attention, executive function, memory) as seen in trials using hyperbaric oxygen therapy (HBOT) and neurostimulation which increases CBF.
Enhances mitochondrial bioenergetics, aiding ATP production in injured neurons.

In a separate, independent clinical trial conducted by MDs that were double board certified in neurology and psychiatry; adults with ADHD were tested. This study was a randomized, double-blind study where the doctors, clinical techs and participants were blinded to whether the individual was using Squirrel Tamer (the therapeutic device), or an "Active Control" which looked and sounded like Squirrel Tamer, but used a different vibrational pattern. This is much more difficult than testing against a placebo, because the Active Control will provide an expected "placebo effect" but may also provide neurostimulation that could be beneficial. So the bar to show a difference is higher. Note that drug trials and other devices typically do not test against anything other than a placebo because its a much more difficult test. 24 different measure of attention and cognitive performance were tested and analyzed by using a computerized test that is similar to WeVibin's Squirrel Chaser app, but more robust for clinical research. This type of testing environment is preferred because the data is black and white with no human interpretation by the doctor or individual. In drug and other studies, the participant is simply asked if they feel like their focus has improved or not (and other questions) and the doctor adjust treatment. This is highly subjective and can lead to further addiction.

Results: As shown in the Active Control showed improvement across 6 of the 24 metrics, while Squirrel Tamer showed improvement across 21 of the 24 metrics. Interestingly, the Active Control showed faster reaction times, but worse scores for auditory & Visual Attention, Focus, Imp[ulsivity and processing. This is similar to other stimulants like coffee. Once can feel like they are more awake and with it, but make more mistakes.

This chart shows all of the detailed results. The first bar in each graph is the Active Control and the second bar in each graph is Squirrel Tamer.

22 of 24 metrics for Squirrel Tamer were higher than the Active Control.

21 of those 22 reached a clinical and statistical difference.

Two scores, Auditory Speed and Visual Speed (i.e. reaction time) actually slowed for Squirrel Tamer, but resulted in better performance across the board.